NMRA – neumora therapeutics, inc. (US:NASDAQ)
Stock Stats
News
Neumora Therapeutics (NASDAQ:NMRA) was upgraded by analysts at Leerink Partnrs to a "strong-buy" rating.
Neumora Therapeutics (NASDAQ:NMRA) is now covered by analysts at Leerink Partners. They set an "outperform" rating and a $8.00 price target on the stock.
Neumora Therapeutics (NASDAQ:NMRA) was given a new $6.00 price target on by analysts at Mizuho.
Neumora Therapeutics Highlights 2026 Pipeline Strategy and Anticipated Upcoming Milestones [Yahoo! Finance]
Neumora Therapeutics Announces Positive Results from NMRA-511 Phase 1b Signal-Seeking Study in Alzheimer's Disease Agitation [Yahoo! Finance]
Form 8-K Neumora Therapeutics, For: Jan 12
Form 4 Neumora Therapeutics, For: Jan 08 Filed by: Milligan Michael Lee
Form 4 Neumora Therapeutics, For: Jan 08 Filed by: Aurora Daljit Singh
Form 4 Neumora Therapeutics, For: Jan 08 Filed by: Duncan Jason
Form 4 Neumora Therapeutics, For: Jan 08 Filed by: Pinto Joshua
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.